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background:  The aging congenital heart disease (CHD) population is prone to develop a variety of sequelae, including pulmonary arterial 
hypertension (PAH). Previous prevalence reports have a high degree of variability, with an overrepresentation of tertiary centers. We aimed to report 
robust prevalence estimates of PAH in adult CHD patients.
methods and results:  We performed a cross-sectional analysis to determine prevalence of PAH in adults with CHD using the population-based 
Dutch Congenital Corvitia (CONCOR) registry. Of 12 624 adults with CHD alive in 2011, 5 487 (44%) had an initial diagnosis of systemic-to-
pulmonary shunt and were thereby at risk for developing PAH. From these patients, a random sample of 1 814 subjects was obtained, mean age 
40±15 years, and 135 PAH cases were observed. Total PAH prevalence in patients born with a systemic-to-pulmonary shunt was 7.4%. A remarkable 
high number of patients had PAH after corrective cardiac surgery, with a prevalence of 5.7%. PAH prevalence increases with age, from 2.5% under 
30 years until 35% in the oldest patients of the study cohort. In the entire CHD population the PAH prevalence was 3.2%. Based on an overall 
prevalence of CHD in the adult population of 3000 per million, we can assume a prevalence of PAH-CHD of 100 per million inhabitants.
conclusion:  Prevalence of PAH in CHD patients is 3.2%, and 100 per million in the general adult population. Especially in patients after corrective 
cardiac surgery and the elderly, physicians should be aware of PAH-CHD, to provide optimal therapeutical and clinical care.
